A new study from Karolinska Institutet in Sweden shows, for the first time, an association between coronary heart disease and oral health in women. Recent results have also shown that serological factors, might provide insight into the reported epidemiological association between periodontitis and cardiovascular disease.
Cardiovascular disease (CVD) is the leading cause of death in the Western industrialized world. Classic risk factors such as smoking, obesity and high blood lipids do not explain all clinical and epidemiological features of CVD. Chronic inflammation has been suggested as a possible “unknown” risk factor. However, the chronic inflammatory disease periodontitis, has only recently been found to be associated to CVD.
A new study from Karolinska Institutet shows, for the first time, an association between coronary heart disease (CHD) and oral health in women. A group of 187 female patients with CHD had fewer remaining teeth (P<0.001) and more pathological periodontal pockets (P=0.002) compared to a control group. Dentures were more frequent (27% vs. 6%) as was edentulousness (10.5% vs. 0%) in the CHD group compared to the controls.
In another recent study from Karolinska Institutet risk factors for CVD were found in plasma from patients with periodontitis. Plasma levels of markers for arteriosclerosis and indices of inflammation in 50 patients with severe periodontitis were compared with those in 46 healthy cases. Total cholesterol levels were similar in the two groups, whereas levels of high density lipoproteins (HDL) were lower (P=0.007) and levels of C-reactive protein (CRP) were higher in the patient group. This is important, as both HDL and CRP are accepted risk factors for arteriosclerosis. Plasma levels of bacterial antigen specific IgA anti-Hsp60 antibodies were also lower in the patient group (P=0.0001). These serological differences might provide insight into the reported epidemiological association between periodontitis and CVD.
A possible mechanism behind the reported association could be the release of bacteria, bacterial products or pro-inflammatory cytokines from the periodontal lesions into the blood stream.
Ulla Bredberg Rådén | Source: alphagalileo
Further information: www.ki.se
More articles from Health and Medicine:
Interferon alpha can delay full onset of type I diabetes
03.07.2009 | University of Texas Health Science Center at Houston
Infants should be screened for hip trouble
03.07.2009 | American Academy of Orthopaedic Surgeons
The least sea ice in 800 years
03.07.2009 | Earth Sciences
Astronomer's new guide to the galaxy: largest map of cold dust revealed
03.07.2009 | Physics and Astronomy
Interferon alpha can delay full onset of type I diabetes
03.07.2009 | Health and Medicine
29.06.2009 | Event News
6th BMBF Forum for Sustainability "Research for Sustainability - One Step Further"
19.06.2009 | Event News
2nd ISPIM Innovation Symposium - Stimulating Recovery The Role of Innovation Management
02.06.2009 | Event News